Brief: Control Bionics Says For Q4 A$1.5M Sales Revenue
25/07/2023 11:18
July 25 (Reuters) - Control Bionics Ltd CBL.AX :
* FOR Q4 , A$1.5M IN SALES REVENUE, UP OVER 20% ON Q3
* STRONG GROWTH TRAJECTORY FROM CORE BUSINESS IS FORECAST TO
CONTINUE THROUGH FY24
* UNAUDITED OPERATING REVENUE FOR FY23 A$5.6 MILLION, UP 27%
Source text for Eikon: ID:nASX4dsMyn
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device